Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/19/2003US20030114433 Anticancer agents
06/19/2003US20030114432 Antiinflammatory agents; rheumatic diseases; anticancer agents
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114393 Use of steroidal alkaloids to reverse multidrug resistance
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113872 Vasopermeability-enhancing conjugates
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113820 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113818 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113750 Diagnosing cancer of urogenital systems using oligonucleotides/peptide nucleic acids or cytosine methylation; matrix assisted laser desorption ionization/electron spray mass spectrometry
06/19/2003US20030113714 Binding peptides to polycrystalline semiconductors; detection of bacteriophages; high density magnetic storage; medical imaging; forensics; antitumor agents; anticarcinogenic agents
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113382 Causing cyclic GMP to increase in the neoplastic cells and exposing neoplastic cells to cisplatin derivative
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113334 Cytotoxic antibodies specifically bind to proteins which were expressed in lymphatic tumors
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113328 Regulation of T cell responses, T cell proliferation, and induction of T cell death
06/19/2003US20030113321 Novel G-protein-coupled receptor protein and its DNA
06/19/2003US20030113311 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient
06/19/2003US20030113306 Probiotic lactobacillus casei strains
06/19/2003US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector)
06/19/2003US20030111087 Process for the isolation of a major harmful oxidant from cigarette smoke
06/19/2003US20030111020 Culture of sessile marine animals
06/19/2003CA2471743A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003CA2469901A1 Use of a labelled ligand having specificity for the human cd4 molecule to produce a diagnostic agent for analysing migration and/or distribution patterns of cell populations
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469792A1 In vitro production of dendritic cells from cd14+ monocytes especially for the preparation of suspension, monolayer and three-dimensional cell and/or tissue models, and use of these models
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469670A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003CA2469615A1 Combination cancer therapy
06/19/2003CA2469613A1 Process for affecting neurologic progression
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469595A1 Treatment of glioblastoma with thymosin-alpha 1
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469483A1 Hematopoietic cells from human embryonic stem cells
06/19/2003CA2469354A1 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469336A1 Guanidinium transport reagents and conjugates
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469274A1 Tumor antigens
06/19/2003CA2469266A1 The method of treating cancer
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469147A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2469045A1 Methods of therapy for non-hodgkin's lymphoma
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/19/2003CA2468994A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468794A1 Treatment of neoplasia
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467916A1 Mitotic kinesin inhibitors
06/19/2003CA2467726A1 Mitotic kinesin inhibitors
06/19/2003CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319404A2 Composition for treating and/or prophylaxis of tumors of the breast
06/18/2003EP1319403A1 Remedies for cisplatin-tolerant cancer
06/18/2003EP1319186A1 Prognostic indicator
06/18/2003EP1319183A2 Methods and products related to low molecular weight heparin
06/18/2003EP1319182A2 G-csf analog compositions and methods
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319014A1 Antisense modulation of flip-c expression
06/18/2003EP1319011A1 Triazolo-epothilones
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1319002A1 Alpha v integrin receptor antagonists
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1319000A1 1-azabicyclo 2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
1 ... 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 ... 2211